Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124

Clinical trial NCT04176653 · WITHDRAWN

Trial details

NCT number: NCT04176653
Sponsor: Silence Therapeutics plc
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Non-transfusion-dependent Thalassemia Low Risk Myelodysplastic Syndrome

Start date: 2019-08-20
Primary completion: 2021-09-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.